# Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma

> **NCT02340130** · PHASE2 · COMPLETED · sponsor: **Laboratorios Leti, S.L.** · enrollment: 57 (actual)

## Conditions studied

- Rhinitis
- Rhinoconjunctivitis
- Asthma

## Interventions

- **BIOLOGICAL:** DP/MG/14-1
- **BIOLOGICAL:** DP/MG/14-2

## Key facts

- **NCT ID:** NCT02340130
- **Lead sponsor:** Laboratorios Leti, S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2018-05
- **Final completion:** 2018-06
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02340130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02340130, "Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02340130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*